Humanigen and Avid Bioservices Enter into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing

NEXT STORY
Brandywine Realty Trust announces Joint Venture with a Global Institutional Investor for its planned 570,000 GSF mixed-use tower at 3025 JFK Blvd within 14-acre, $3.5 billion Schuylkill Yards Neighborhood
PREV STORY
Affimed Announces Collaboration with Roche to Study AFM24 in Combination with PD-L1 Checkpoint Inhibitor in EGFR Expressing Solid Tumors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Humanigen and Avid Bioservices Enter into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing

NEXT STORY
Brandywine Realty Trust announces Joint Venture with a Global Institutional Investor for its planned 570,000 GSF mixed-use tower at 3025 JFK Blvd within 14-acre, $3.5 billion Schuylkill Yards Neighborhood
PREV STORY
Affimed Announces Collaboration with Roche to Study AFM24 in Combination with PD-L1 Checkpoint Inhibitor in EGFR Expressing Solid Tumors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

electroCore, Inc. Announces Extension of NHS England’s Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore™ in England

author_avatar
NASDAQ Market News

Heat Biologics to Present Topline HS-410 Phase II Bladder Cancer Results at the Society of Urological Oncology Annual Meeting

DURHAM, N.C., Nov. 16, 2016 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq:HTBX), a leader ...

author_avatar
NASDAQ Market News

Nabriva Therapeutics and Roivant Sciences Enter into License Agreement to Develop and Commercialize Lefamulin in Greater China

DUBLIN, Ireland and HONG KONG, March 27, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), ...

author_avatar
NASDAQ Market News